On October 22, 2025, the management of QazBioPharm National Holding JSC held a meeting with representatives of Zhongnong Weite Biotechnology Co., Ltd. and the Lanzhou Veterinary Research Institute, key institutions specializing in the development and production of veterinary vaccines in China, as well as with the domestic manufacturer Biotron Group.

During the visit, Ergali Abduraimov, Chief Executive Officer of QazBioPharm, introduced the guests to the activities of the Holding and its subsidiaries. In turn, the Chinese representatives presented information about the main areas of work and scientific developments of their organizations.

The parties discussed areas of cooperation in the field of biological safety, including the production of immunobiological products for animals. Particular attention was given to the production capacities of the Chinese enterprises, opportunities for investment cooperation and technology transfer, as well as the exchange of experience between researchers and practitioners through professional internships and advanced training programs.

Following the meeting, both sides expressed their readiness to continue the dialogue and to explore concrete mechanisms for implementing joint research and production projects.